相关实验视频

Updated: May 12, 2025

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

咖啡酸酸功能化线性多糖醇用于针对性siRNA输送,用于治疗原发性胆道胆炎

Ying Liu¹, Haixia Ma², Qiange Zhang³

¹Affiliated Changshu Hospital of Nantong University, No. 18 Taishan Road, Changshu City, Jiangsu Province, China.

International journal of biological macromolecules

|May 7, 2025

概括

一种新型的CAPG微粒有效地将siRNA输送到肝脏,准蛋白质氨酸甲基转移酶5 (PRMT5) 来治疗一次性胆道胆炎 (PBC). 这种方法可以减少肝脏炎症,并优于自由siRNA.

科学领域:

生物医学工程生物医学工程
药物输送系统药物输送系统
肝病学肝病学是一种肝病学.

背景情况:

用siRNA准蛋白质氨酸甲基转移酶5 (PRMT5) 对一次性胆道胆炎 (PBC) 治疗有希望.
治疗药物的有效和特异性输送到肝脏仍然是治疗PBC的一个重大挑战.

研究的目的:

开发一种新型菌根系统 (CAPG),以有效地向肝脏输送针对PRMT5.5的siRNA.
在肝炎的小鼠模型中评估CAPG输出的siRNA的治疗疗效.

主要方法:

咖啡酸酸衍生线性多聚糖醇聚合物微粒 (CAPG) 的开发.
在高ROS和酸性环境中微粒降解的体外评估.
在小鼠体内评估siRNA1@CAPG,测量肝炎生物标志物,促炎因素和PRMT5表达.

主要成果:

CAPG小粒有效地将siRNA传递到肝脏.
在炎症环境中微细胞的降解促进了siRNA的释放.
siRNA1@CAPG显著降低了肝炎生物标志物和促炎因素.
siRNA1@CAPG显著增加了超氧化物脱酶 (SOD) 水平,并比自由siRNA1.1更有效地抑制了PRMT5的表达.

结论:

CAPG小粒代表了针对性siRNA向肝脏输送用于PBC治疗的有希望的策略.
开发的系统有效降低肝炎和PRMT5表达.
这项研究为开发初级胆道胆道炎的先进疗法提供了宝贵的参考.

关键词:

具有双重响应能力.线性多糖醇多糖醇是一种线性多糖醇多醇.聚合物微粒是一种聚合物.原发性胆道胆管炎是一种胆道胆管炎.蛋白质氨酸甲基转移酶5 (PRMT5) 是一种

更多相关视频

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

相关概念视频

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...